Literature DB >> 23624096

Diversity of circulating rotavirus strains in children hospitalized with diarrhea in India, 2005-2009.

Gagandeep Kang1, Rishi Desai, Rashmi Arora, Shobha Chitamabar, Trilok Nath Naik, Triveni Krishnan, Jagdish Deshpande, Mohan D Gupte, S Venkatasubramaniam, Jon R Gentsch, Umesh D Parashar, Ann Mathew, Sasirekha Ramani, Thuppal V Sowmynarayanan, Prabhakar D Moses, Indira Agarwal, Anna Simon, Anuradha Bose, Ritu Arora, Preeti Chhabra, Prachi Fadnis, Jyoti Bhatt, Sushmita J Shetty, Vinay Kumar Saxena, Meenakshi Mathur, Alka Jadhav, Soumyabrata Roy, Anupam Mukherjee, Ng Brajachand Singh.   

Abstract

BACKGROUND: India accounts for 22% of the 453,000 global rotavirus deaths among children <5 years annually. The Indian Rotavirus Strain Surveillance Network provides clinicians and public health partners with valuable rotavirus disease surveillance data. Our analysis offers policy-makers an update on rotavirus disease burden with emphasis on regional shifts in rotavirus strain epidemiology in India.
METHODS: Children <5 years requiring hospitalization for acute gastroenteritis were selected from 10 representative hospitals in 7 cities throughout India between November 2005 through June 2009. We used a modified World Health Organization protocol for rotavirus surveillance; stool specimens were collected and tested for rotavirus using enzyme immunoassay and reverse-transcription polymerase chain reaction.
RESULTS: A total of 7285 stool specimens collected were tested for rotavirus, among which 2899 (40%) were positive for rotavirus. Among the 2899 rotavirus detections, a G-type could not be determined for 662 (23%) and more than one G type was detected in 240 (8%). Of 1997 (69%) patients with only one G-type, the common types were G1 (25%), G2 (21%), G9 (13%), and G12 (10%). The proportion of rotavirus infections attributed to G12 infections rose from 8% to 39% in the Northern region and from 8% to 24% in the Western region.
CONCLUSIONS: This study highlights the large, ongoing burden of rotavirus disease in India, as well as interesting regional shifts in rotavirus strain epidemiology, including an increasing detection of G12 rotavirus strains in some regions. While broad heterotypic protection from rotavirus vaccination is expected based on pre- and post-licensure data from other settings, effectiveness assessments and rotavirus strain monitoring after vaccine introduction will be important. Published by Elsevier Ltd.

Entities:  

Mesh:

Year:  2013        PMID: 23624096     DOI: 10.1016/j.vaccine.2013.04.030

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  15 in total

1.  Emergence of Rotavirus G12P[8] in St. Louis During the 2012-2013 Rotavirus Season.

Authors:  Kristine M Wylie; George M Weinstock; Gregory A Storch
Journal:  J Pediatric Infect Dis Soc       Date:  2014-09-15       Impact factor: 3.164

Review 2.  Review of global rotavirus strain prevalence data from six years post vaccine licensure surveillance: is there evidence of strain selection from vaccine pressure?

Authors:  Renáta Dóró; Brigitta László; Vito Martella; Eyal Leshem; Jon Gentsch; Umesh Parashar; Krisztián Bányai
Journal:  Infect Genet Evol       Date:  2014-09-16       Impact factor: 3.342

3.  Restriction fragment length polymorphism analysis of rotavirus VP7-encoding gene from humans and animals of Northeast India: a relative study of Indian and global isolates.

Authors:  P Chakraborty; N N Barman; I Sharma
Journal:  Epidemiol Infect       Date:  2015-01-09       Impact factor: 4.434

4.  Epidemiology and genetic diversity of human parechoviruses circulating among children hospitalised with acute gastroenteritis in Pune, Western India: a 5-years study.

Authors:  P R Patil; N N Ganorkar; V Gopalkrishna
Journal:  Epidemiol Infect       Date:  2017-11-27       Impact factor: 4.434

5.  Human G3P[4] rotavirus obtained in Japan, 2013, possibly emerged through a human-equine rotavirus reassortment event.

Authors:  Rungnapa Malasao; Mayuko Saito; Akira Suzuki; Toshifumi Imagawa; Nao Nukiwa-Soma; Kentaro Tohma; Xiaofang Liu; Michiko Okamoto; Natthawan Chaimongkol; Clyde Dapat; Kazuhisa Kawamura; Yasuko Kayama; Yoshifumi Masago; Tatsuo Omura; Hitoshi Oshitani
Journal:  Virus Genes       Date:  2014-10-29       Impact factor: 2.332

6.  Whole Genomic Analysis of Human G12P[6] and G12P[8] Rotavirus Strains that Have Emerged in Myanmar.

Authors:  Tomihiko Ide; Satoshi Komoto; Kyoko Higo-Moriguchi; Khaing Win Htun; Yi Yi Myint; Theingi Win Myat; Kyaw Zin Thant; Hlaing Myat Thu; Mo Mo Win; Htun Naing Oo; Than Htut; Mitsutaka Wakuda; Francis Ekow Dennis; Kei Haga; Yoshiki Fujii; Kazuhiko Katayama; Shofiqur Rahman; Sa Van Nguyen; Kouji Umeda; Keiji Oguma; Takao Tsuji; Koki Taniguchi
Journal:  PLoS One       Date:  2015-05-04       Impact factor: 3.240

Review 7.  Differences of Rotavirus Vaccine Effectiveness by Country: Likely Causes and Contributing Factors.

Authors:  Ulrich Desselberger
Journal:  Pathogens       Date:  2017-12-12

8.  Human rotavirus strains circulating in Venezuela after vaccine introduction: predominance of G2P[4] and reemergence of G1P[8].

Authors:  Esmeralda Vizzi; Oscar A Piñeros; M Daniela Oropeza; Laura Naranjo; José A Suárez; Rixio Fernández; José L Zambrano; Argelia Celis; Ferdinando Liprandi
Journal:  Virol J       Date:  2017-03-21       Impact factor: 4.099

9.  Prevalence and genetic diversity of rotavirus infection in children with acute gastroenteritis in a hospital setting, Nairobi Kenya in post vaccination era: a cross-sectional study.

Authors:  Mary-Theresa Agutu; Julliette Ongus; Janeth Kombich; Rose Kamenwa; James Nyangao; John Kagira; Adelaide Ayoyi Ogutu; Austine Bitek
Journal:  Pan Afr Med J       Date:  2017-01-24

10.  Rotavirus Surveillance at a WHO-Coordinated Invasive Bacterial Disease Surveillance Site in Bangladesh: A Feasibility Study to Integrate Two Surveillance Systems.

Authors:  Arif Mohammad Tanmoy; Asm Nawshad Uddin Ahmed; Rajesh Arumugam; Belal Hossain; Mahfuza Marzan; Shampa Saha; Shams El Arifeen; Abdullah H Baqui; Robert E Black; Gagandeep Kang; Samir Kumar Saha
Journal:  PLoS One       Date:  2016-04-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.